Patients with higher levels of serum fibrinogen have higher rates of progression.
Elevated serum levels of fibrinogen are associated with the development of diabetic end-stage renal disease (ESRD) in patients with type 2 diabetes mellitus, according to study findings published online in Diabetes Research and Clinical Practice.
In a study of 174 patients with type 2 diabetes mellitus and biopsy-proven diabetic nephropathy, Junlin Zhang, MD, PhD, and colleagues at West China Hospital of Sichuan University in Chengdu, China, found that patients in the second, third, and fourth quartiles of serum fibrinogen had a significant 7.1-, 5.8-, and 8.8-fold increased risk of progressing to ESRD compared with those in the first quartile.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.
